By Martin Grueber, Research Leader, Battelle, Cleveland, Ohio and Tim Studt, Editor in Chief, Advantage Business Media
Tuesday, December 22, 2009
|
Barbara Kunz, President
Battelle Health & Life Sciences Global Business
|
The past several decades have heralded a revolution in the fundamental understanding of disease and disease progression. In particular, researchers have come to recognize the interconnectivity that exists between cellular tissue and organ systems in mammals, and that one system can no longer be studied in isolation.
This ever-expanding comprehension of disease has had a dramatic impact on new healthcare solutions, from foundational research conducted by the National Institutes of Health and universities to developing novel therapeutics, diagnostics, and delivery technologies, to evolving requirements of our public health system that are rooted in our ability to respond to potential pandemics via safe and effective countermeasures.
Significant challenges face global healthcare and our ability to remotely access and treat populations around the world. Battelle’s comprehensive focus on health and life sciences will continue to enable us to serve as an unbiased entity in addressing these issues. We recognize the importance of leveraging our scientific and technical expertise to develop practical solutions for these challenges. This level of support is critical to meet the demands of our evolving, sophisticated scientific system that impacts the human condition and the world in which we live.
Battelle’s investments in R&D are critical in advancing science and accelerating innovative solutions for human health and, more specifically, are at the nexus of the sciences of biotechnology, nanotechnology and informatics. Our health research programs are focused on understanding chronic and infectious diseases at the molecular level, making advances in systems biology and disease progressions to deliver novel diagnostics and drugs, and developing sustainable healthcare delivery through the public health system.
